11-134157060-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015261.3(NCAPD3):c.4210G>A(p.Glu1404Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000248 in 1,613,594 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_015261.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NCAPD3 | NM_015261.3 | c.4210G>A | p.Glu1404Lys | missense_variant | 32/35 | ENST00000534548.7 | NP_056076.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NCAPD3 | ENST00000534548.7 | c.4210G>A | p.Glu1404Lys | missense_variant | 32/35 | 1 | NM_015261.3 | ENSP00000433681.3 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152048Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000151 AC: 38AN: 251102Hom.: 0 AF XY: 0.000155 AC XY: 21AN XY: 135706
GnomAD4 exome AF: 0.000261 AC: 381AN: 1461546Hom.: 0 Cov.: 30 AF XY: 0.000252 AC XY: 183AN XY: 727050
GnomAD4 genome AF: 0.000125 AC: 19AN: 152048Hom.: 0 Cov.: 32 AF XY: 0.0000943 AC XY: 7AN XY: 74256
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 24, 2023 | The c.4210G>A (p.E1404K) alteration is located in exon 32 (coding exon 32) of the NCAPD3 gene. This alteration results from a G to A substitution at nucleotide position 4210, causing the glutamic acid (E) at amino acid position 1404 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at